NCI (Neo-Concept International Group Holdings Limited Class A Ordinary Shares) Stock Analysis - News

Neo-Concept International Group Holdings Limited Class A Ordinary Shares (NCI) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, NCI trades at $9.06 with a market cap of $2.36M and a P/E ratio of 4.03. NCI moved +1.54% today. Year to date, NCI is -7.58%; over the trailing twelve months it is -48.24%. Its 52-week range spans $2.56 to $110.48. Rallies surfaces NCI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in NCI news today?

Neo-Concept International Raises $8.1M with 14.85M Shares, Stock Jumps 13%: Neo-Concept International closed a public offering on Feb. 11 by issuing 14.85 million Class A shares at $0.5454 each, raising $8.1 million in gross proceeds. Shares surged over 13%, trading near $2.63—about 90% above the 20-day SMA—and approaching key resistance at $3 with bullish MACD strength and neutral RSI.

NCI Key Metrics

Key financial metrics for NCI
MetricValue
Price$9.06
Market Cap$2.36M
P/E Ratio4.03
EPS$2.17
Dividend Yield0.05%
52-Week High$110.48
52-Week Low$2.56
Volume1.22K
Avg Volume0
Revenue (TTM)$806.75M
Net Income$98.12M
Gross Margin26.20%

Latest NCI News

NCI Analyst Consensus

NCI analyst coverage data. Average price target: $0.00.

Common questions about NCI

What changed in NCI news today?
Neo-Concept International Raises $8.1M with 14.85M Shares, Stock Jumps 13%: Neo-Concept International closed a public offering on Feb. 11 by issuing 14.85 million Class A shares at $0.5454 each, raising $8.1 million in gross proceeds. Shares surged over 13%, trading near $2.63—about 90% above the 20-day SMA—and approaching key resistance at $3 with bullish MACD strength and neutral RSI.
Does Rallies summarize NCI news?
Yes. Rallies summarizes NCI news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NCI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NCI. It does not provide personalized investment advice.
NCI

NCI